China — Advanced Healthcare & Medical Innovation
China is an important destination for patients exploring advanced specialist healthcare, medical technologies and emerging treatment approaches.
Across major medical centres in Beijing, Shanghai, Guangzhou, Hangzhou and other cities, hospitals offer services in oncology, precision diagnostics, neurosurgery and complex multidisciplinary care.
Advanced Cancer Care & Precision Medicine
China’s specialist cancer centres are developing and applying increasingly sophisticated approaches to cancer diagnosis and treatment.
These include molecular profiling, targeted therapies, immunotherapy, cellular therapies and multidisciplinary treatment planning.
CAR-T cell therapy is an important area of development, particularly for certain blood cancers. Investigational applications for solid tumours are also being studied, although eligibility, regulatory status and clinical evidence vary considerably.
Patient-derived tumour organoid testing is another emerging field. It may provide additional laboratory information about potential drug responses, but its clinical usefulness depends on the cancer type, testing methods and available evidence.
Functional Neurosurgery
Specialist centres in China also provide neurological assessment and selected treatments for movement disorders and other complex neurological conditions.
These may include deep brain stimulation (DBS) and MRI-guided focused ultrasound (MRgFUS), subject to specialist evaluation and individual suitability.
Hospitals & Specialist Healthcare Providers
Glowcations Asia aims to help international patients explore appropriate healthcare providers and understand their treatment options.
Our existing healthcare network includes information about specialist providers such as GoBroad Healthcare Group and Xi’an Chang’an Hospital.
Further hospital profiles and treatment guides will be developed as our China healthcare network expands.
Specialist Neuro-Oncology in Beijing
China’s specialist healthcare capabilities continue to develop, including multidisciplinary care for complex brain and nervous system tumours.
GoBroad Healthcare Group’s new Comprehensive Neuro-Oncology Center in Beijing brings together precision diagnostics, specialist assessment, clinical research and long-term follow-up under the leadership of Professor Wenbin Li.
Read our Glowcations Asia report on GoBroad’s Neuro-Oncology Center for further information about the centre and considerations for international patients.
Advanced Cancer Research in China: GoBroad at ESMO 2026
China’s growing involvement in international oncology research is reflected in the findings presented by GoBroad Healthcare Group and collaborating research teams at the European Society for Medical Oncology (ESMO) Congress 2026.
Their research contributions covered emerging approaches to melanoma immunotherapy, CAR-T therapy for colorectal cancer, antibody-drug conjugates and targeted treatments for selected brain tumours.
For international patients, these developments highlight the importance of distinguishing promising clinical research from approved and routinely available treatments.
Read more: GoBroad at ESMO 2026: New Directions in Cancer Treatment Research.
International Patient Support
Seeking treatment overseas requires careful consideration of diagnosis, treatment eligibility, medical records, costs, travel requirements and follow-up arrangements.
Patients should obtain independent medical advice and confirm the qualifications, licensing and treatment capabilities of any healthcare provider before making decisions.
Explore Our Existing China Healthcare Resources
Our established Medical Tourism Vietnam platform also provides information about specialist healthcare services and selected hospitals in China.
Glowcations Asia will complement these existing resources rather than replace established pages and links.